CENTOGENElogo.jpg
CentoMD® Update Reveals Continued Growth of Rare Hereditary Disease Knowledge Base
December 16, 2019 06:37 ET | Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany, Dec. 16, 2019 (GLOBE NEWSWIRE) -- In an update released today by CENTOGENE (Nasdaq: CNTG) to CentoMD® - the Company’s data repository of epidemiologic,...
CENTOGENElogo.jpg
CENTOGENE Expands Executive Leadership Team
December 06, 2019 06:00 ET | Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany, Dec. 06, 2019 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG) today announced the expansion of its executive leadership team with the appointment of Philip...
CENTOGENElogo.jpg
Centogene reporting its financial results for the three months and nine months ended September 30, 2019
December 05, 2019 06:28 ET | Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 05, 2019 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world...
CENTOGENElogo.jpg
CENTOGENE to Announce Third Quarter 2019 Financial Results on 5th December 2019
December 02, 2019 03:00 ET | Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 02, 2019 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world...
CENTOGENElogo.jpg
CENTOGENE gibt vorübergehende Auszeit von Holger Friedrich von Position als Aufsichtsrat bekannt
November 21, 2019 08:54 ET | Centogene AG
ROSTOCK, Deutschland und BERLIN und CAMBRIDGE, Mass., Nov. 21, 2019 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), ein auf seltene Erkrankungen spezialisiertes Unternehmen, welches klinische und...
CENTOGENElogo.jpg
CENTOGENE Announces Temporary Leave of Absence of Holger Friedrich from the Supervisory Board
November 21, 2019 08:54 ET | Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 21, 2019 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical...
CENTOGENElogo.jpg
CENTOGENE Signs New Collaboration with PTC Therapeutics for Global Diagnostic Testing Program
November 18, 2019 08:00 ET | Centogene AG
CAMBRIDGE, Ma. and ROSTOCK, Germany, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Centogene N.V. (NASDAQ: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and...
CENTOGENElogo.jpg
CENTOGENE Signs Data Access and Collaboration Agreement with Pfizer Inc.
November 13, 2019 03:23 ET | Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 13, 2019 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG),  a commercial-stage company focused on rare diseases that transforms real-world clinical...
CENTOGENElogo.jpg
CENTOGENE Announces Pricing of Initial Public Offering
November 07, 2019 03:12 ET | Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Centogene B.V. (“Centogene” or the “Company”), a commercial-stage company focused on rare diseases that transforms real-world...
CENTOGENElogo.jpg
CENTOGENE Announces Proposed Initial Public Offering of Common Shares
October 28, 2019 08:54 ET | Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Centogene B.V. (“Centogene” or the “Company”), a commercial-stage company focused on rare diseases that transforms real-world...